MedPath

se of Pippalimool Churna and Shudha Hingu in the Management of After Pain (Sutika Makkal Shool)

Phase 3
Conditions
Health Condition 1: O908- Other complications of the puerperium, not elsewhere classified
Registration Number
CTRI/2024/05/066657
Lead Sponsor
Dr Mahjabeen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age group 18-45 yr all puerpera irrespective of parity.

All puerpera with vaginal deliveries complaining of Makkal Shool.

Puerpera between 1st to 10th day will be selected.

Exclusion Criteria

Puerpera with operative deliveries.

All other puerperal complications excluding Sutika Makkal Shool.

Any severe chronic systemic disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in After Pain during puerperium.Timepoint: 1 week <br/ ><br>The trial drug will be given for 1 week with anupana and follow up 2 days after cessation of medicine.
Secondary Outcome Measures
NameTimeMethod
Relief in mutrasanga & anaha.Timepoint: After analyzing all the parameters the result will be assessed on the basis of symptomatic relief & improvement. <br/ ><br>Partially improvement after 1 hour- pateint get 40-60 percent relief from sign & symptoms <br/ ><br>Improvement after 24 hrs- pateint get 60-80 percent relief from sign & symptoms <br/ ><br>Cured after 1 week-pateint get 80-100 percent relief from sign & symptoms.
© Copyright 2025. All Rights Reserved by MedPath